Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
REMS changes and follow-up flexibility
Dr Lunning describes REMS history, rationale, and new flexible monitoring/driving guidance for authorized centers.
Play episode from 30:37
Transcript
